QUINCE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.06 USD | +0.95% |
|
+5.47% | +0.95% |
| Apr. 01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 26 | Transcript : Quince Therapeutics, Inc. - Special Call |
Chart calendar Quince Therapeutics, Inc.
b010ca.pY_mDNOL-GLS8iehx7O4XRDyvUtg2wEDsaHJz9INSc0._cm1bYrTnzCdkU_TjN3NO0S0iAUotU9Egvmv-YdUfPrz6YpkivisC_-IHw~77779d1e3e8260b6c4352f17280effa6
Upcoming events on Quince Therapeutics, Inc.
Past events on Quince Therapeutics, Inc.
| 2024-04-01 07:00 am | Q4 2023 Earnings Release |
| 2024-02-14 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-09 06:30 pm | Biotech Showcase |
| 2024-01-07 02:00 pm | Neuroscience Innovation Forum |
| 2023-08-17 03:15 pm | Sidoti Virtual Investor Conference |
| 2023-07-24 07:00 am | Acquisition of EryDel SpA By Quince Therapeutics Inc Call |
| 2023-05-24 02:00 pm | Annual General Meeting |
| 2022-09-11 | Military Health System Research Symposium |
| 2022-09-08 | American Society for Bone and Mineral Research Meeting |
| 2022-08-29 | Osteogenesis Imperfecta International Conference |
| 2022-08-11 09:00 am | Canaccord Growth Conference |
| 2022-08-08 | Interim 2022 Earnings Release |
| 2022-06-08 02:00 pm | Annual General Meeting |
| 2022-05-14 | Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases International Conference |
| 2022-03-20 05:50 am | Alzheimer and Parkinson Diseases and Related Neurological Disorders International Conference |
| 2021-11-30 01:25 pm | Evercore ISI HealthCONx Conference |
| 2021-11-11 11:35 am | Clinical Trials on Alzheimer's Disease Conference |
| 2021-11-08 | Clinical Trials on Alzheimer's Disease Conference |
| 2021-10-26 04:30 pm | Business Update Call |
| 2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -39,0 -37,9 -2.89% | -78,6 -80,5 2.36% | -90,0 -89,7 -0.28% |
|
EBIT Million USD | Released Forecast Spread | -39,2 -37,7 -3.85% | -78,9 -81,1 2.68% | -90,3 -89,5 -0.87% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,0 -35,8 -3.32% | -76,8 -79,0 2.78% | -89,9 -89,9 -0.03% |
|
Net income Million USD | Released Forecast Spread | -37,0 -35,8 -3.39% | -76,8 -78,9 2.55% | -89,9 -89,2 -0.79% |
|
EPS USD | Released Forecast Spread | -1,94 -2,03 4.21% | -2,63 -2,59 -1.43% | -3,03 -2,80 -8.37% |
| Announcement Date | 16/03/20 | 01/03/21 | 01/03/22 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -23,5 -22,9 -2.45% | -21,8 -11,9 -83.4% | -16,2 -12,9 -25.38% |
|
EBIT Million USD | Released Forecast Spread | -23,5 -23,6 0.42% | -21,9 -16,8 -29.89% | -16,3 -18,3 11.01% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,4 -21,3 -9.84% | -21,6 -17,6 -22.68% | -16,8 -18,1 7.12% |
|
Net income Million USD | Released Forecast Spread | -23,4 -21,7 -7.89% | -21,6 -16,7 -29.63% | -16,6 -18,1 8.69% |
|
EPS USD | Released Forecast Spread | -0,78 -0,65 -19.63% | -0,72 -0,60 -19.34% | -0,51 -0,61 15.93% |
| Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-23 | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-23 | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-23 | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-24 | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| 2024-04-24 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Past sector events for Quince Therapeutics, Inc.
| Today | SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-22 04:15 pm | MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QNCX Stock
- Calendar Quince Therapeutics, Inc.
